E

Evotec SE
D

EVO

4.41000
USD
-0.95
(-17.65%)
Market Open
Volume
18,941
EPS
-0
Div Yield
-
P/E
-9
Market Cap
1,566,020,847
News

Title: Evotec SE

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000employees and 18 production sites mainly in Europe and the United States.